pharmatec gmbh units for the production, storage and
TRANSCRIPT
Lorem ipsum dolor sit | �
Pharmatec GmbHUnits for the Production, Storage and Distribution of High-purity Media
www.fa
berm
olde
nhau
er.de
0004/01
Pharmatec GmbHA Bosch Packaging Technology Company
Manfred-von-Ardenne-Ring 5 01099 Dresden GermanyTel. +49 351 2 82 78-0Fax +49 351 2 82 78-20www.pharmatec.de
Printed in Germany100 % chlorine free paper
High-purity Media Systems | �
Contact Pharmatec for the planning, development
and production of: Ñ High-purity steam generatorsÑ Distillation unitsÑ HPW generationÑ Storage and distribution systems
for high-purity water and high-purity steam
Pharmaceutical products have a constant need for high-
purity media such as purified water, water for injection
and high-purity steam. Quality fluctuations or supply
bottlenecks for these sensitive pharmaceutical raw
materials are inacceptable for producers. In other
words, high-purity systems are central supply systems
which, if they fail or if the quality drops, can lead to far-
reaching consequences in the production units.
OverviewÑ Planning support to help decisions about the most
efficient solution (feasibility study on request)Ñ Basic and detailed engineering services going
as far as qualification (including full-loop calibration)Ñ Complete FAT in realistic operating conditions
(on request: including endotoxin challenge test)Ñ Customized sizes and functionsÑ Connections to process control systems (PCS)Ñ Individualized software applicationsÑ User ID password protection to 21 CFR Part 11Ñ Systems integration, e.g. feed water header
and WFI tankÑ Support with on-site installationÑ Remote maintenance using modem
High-purity steam generators from Pharmatec
Pharmatec is your partner for the development,
construction and manufacturing of individual high-
purity steam generators. To meet fast deadlines or
budget limitations, Pharmatec can provide standard
solutions with no reduction in quality.
Type pressure (bar) 4 bar (ü) 6 bar (ü) 8 bar (ü)
PSG 50 E 2 50 50 50
PSG 100 E 2 100 100 100
PSG 200 E 2 200 200 200
PSG 200 2 45 80 105
3 50 80
PSG 250 2 95 160 215
3 110 165
PSG 300 2 190 325 410
3 220 330
PSG 400 2 375 650 730
3 440 660
PSG 500 2 480 850 1120
3 165 600 890
4 355 685
PSG 600 2 690 1220 1600
3 240 860 1280
4 510 980
PSG 650 2 1130 2000 2900
3 395 1405 2085
4 840 1600
PSG 700 2 1650 2650 3800
3 505 2000 3250
4 1120 2210
PSG 800 2 2105 3770 4940
3 735 2630 3930
4 1560 3000
PSG 1000 2 2630 4730
3 915 3290 4950
4 1935 3790
High purity media units from Pharmatec
High-purity steam generators from Pharmatec can be used to produce from small to very large quantities of sterile, high-purity pyrogen-free steam. This high-purity steam is suited for: Ñ Sterilizing fittings (tanks, prepa-
ration vessels, piping systems, filling machines, filters, etc.)
Ñ Humidification of air in clean rooms with WFI quality steam
Optional: Membrane gas removal A compact vacuum gas removal unit basically consists of a membrane pipe module and a vacuum pump. It works on the basis of gas permeation through a semi-permeable membrane, by applying a vacuum to a filtration module through which the feed water flows. The unit is construc-ted so that there is no drop in high-purity steam produc-tion when the feed water degasifier is switched on or operated.
High-purity steam quantity (kg/h) for pressurized heating steam High-purity steam
Example of a PSG 500 high-purity steam generator
Optional: Thermal gas removal Thermal non-condensable gas removal can be used in special cases and with ozone sanitized systems. It is based on extracting the finely atomized feed water vapor in a degasifying tank. In this process, the feed water is conducted via a heat exchanger, where it is heated to a gas removal temperature, then nebulised using a spray nozzle into a tank which is surrounded by a vacuum.
Performance features
If a customer has a special request or requirements for the
removal of inert gases within the high-purity steam, in
accordance with EN285 and HTM2010, with proportions
< 3.5 by volume, Pharmatec can deliver degassing systems to
pre- treat the feedwater. We have membrane or thermal
degassing for this application.
High-purity Media Systems | �
Pharmatec high-purity media generators are constructed
following the principle of the natural circulation evapo-
rator. Here, special shell-and-tube heat exchangers are
used. The distillation process is based on an energy-
saving multi-stage principle. Driven by the density
gradient, the power of the natural circulation process is
used to create a circulating flow without any additional
energy. Our engineers and energy experts are constantly
improving the energy-efficient methods for the benefit of
our customers.
Multi-stage pressure column distillation units from Pharmatec
High-performance units for the genera-tion of high-purity media from Pharmatec
Type 4 bar (ü) 6 bar (ü) 8 bar (ü)
50-S1E* 50 50 50
100-S1E* 100 100 100
50-S1 45 80 100
120-S3 160 220 265
200-S3 250 350 410
250-S4 320 450 540
400-S4 420 680 840
500-S4 660 900 1100
700-S4 790 1270 1450
700-S5 790 1270 1450
1000-S5 1060 1700 2050
1000-S6 1060 1700 2050
1500-S5 1530 2450 3100
1500-S6 1530 2450 3100
2000-S5 1950 3150 4100
2000-S6 1950 3150 4100
3000-S6 3100 5060 6100
3500-S6 3600 5060 6100
4000-S6 3950 6150 8100
6000-S7 4900 8500 12100
Multi-stage pressure column distilla-tion units from Pharmatec These units consist of three to eight columns. The first is heated with steam (optionally: electricity). The proceeding columns are heated using the high-purity steam produced by the previous columns. The conti-nuous monitoring of the distillate by the control system means that distillate of insufficient quality is rejected. This includes too high conductivity or a non-permissible temperature.
Pharmatec multi-stage distillation units are designed for
the production of sterile, non-pyrogenic water for injec-
tion (WFI). Only the first column of the distillation unit
needs to be heated with plant steam. In the case of
units with seven to eight columns with the use of
pre-heaters, the WFI product cooler is not required,
as an external cooling medium is not needed.
Optional: Triple mode still As well as the generation of WFI, there is often a need in pharmaceutical processing units for fairly small quanti-ties of high-purity steam, e.g. to sterilize sampling devices, lab equipment or short pipe sections. The first column can optionally be used as an indepen-dent high-purity steam generator. Small quantities of high-purity steam can also be removed at the same time, i. e. simultaneously, during the distillation process.
Example of a multi-stage pressure column distillation unit, type 1000-S6
Distillate production (l/h) with pressurized heating steam
Performance features (*electric heating)
Pharmatec multi-stage distillation units’ unique pro-
cess for eliminating pyrogens is based on the com-
plete separation of the feed water and generated
steam, with low steam rates. A specially developed
baffle/reversing system is designed to almost entirely
remove water drops from the steam produced in
accordance with pharmaceutical laws.
Conceptual diagram of „Blow down“
Concept sketch of Pharmatec Natural circulation evaporator Concept sketch of „Triple mode still“
feed water
pure steam
heating steam
condensate
coolingwater
WFI
waste
„ON“ for WFI generation
„ON“ for RD generation
„ON“ for combinedWFI/RD generation
High-purity Media Systems | �
Successful projects start with project management Ñ Efficient, transparent project management: we
constantly inform you about the project’s progressÑ Pharmatec is certified in accordance with
DIN EN ISO 9001:2000Ñ Shorter delivery times for fast-track projects
available on request
Successful projects need qualified staff Ñ Process engineers and software engineers with many
years’ processing expertise in planning, construction
and automationÑ Practice-oriented mechanics, orbit welders and flexible
fitters in production and final assemblyÑ Experienced service technicians can take on various
tasks on our customers’ sites Ñ Specialists and experienced qualified staff fulfill our
customers’ individual requirements and wishes
Successful projects can be provenÑ Manufacturing traceabilityÑ Documentation – in all main languages –
from the first R & I draft until handoverÑ cGAMP documentation
Successful projects end with a high-quality product
which meets your demands Ñ Compact construction with minimum floor space requiredÑ Parts which come into contact with products come com-
pletely in premium steel 1.4404/1.4435 (AISi 316L) Ñ Frame profile, insulating sheath and switch cabinet in
premium steel (AISi 304)Ñ Control components from Siemens, Allen-Bradley,
Schneider TelemecaniqueÑ Manufactured in accordance with the European Pressure
Equipment Directive 97/23/EC, ASME, SVTI, CODAPÑ Exceeds all requirements in the United States
Pharmacopeia (USP), European PharmacopeiaÑ Effective separation of pyrogens at low steam speedsÑ Suited for low or changing pressure of heating steam or
feed waterÑ Improved setup for high efficiency
On request: Ñ Ra < 0,5 µm surface qualities and electropolishingÑ Delta-ferrite content of 0.5 % to 1 % Ñ Specially manufactured fittings and meters
In pharmaceutical production, high-purity media systems
are used to supply the most important processes. High-
purity media such as WFI and PW are generated, stored,
distributed and used. So that enough medium of suffi-
cient quality is available for every recipient at all times,
the storage and distribution system is customized to
precisely suit the requirements of the production or lab
area.
Requirements for the material, the selection of the
components themselves and the fulfillment of legal
regulations for pharmaceutical construction play a deci-
sive role in fulfilling the high quality requirements for
WFI and PW storage systems.
Ñ GMP- and FDA-compliant setup and adaptation of
production efficiency to fit with storage capacity and
quantities purchasedÑ Validation and guaranteeing of parameters critical
to the process (flow rate, throughput, pressure,
temperature, conductivity)Ñ FAT at Pharmatec – on test benches with equipment
to provide realistic proof that the unit fulfils all user
requirement specifications (URS)Ñ Route planningÑ Tap connection managementÑ Assembly management
Storage and distribution systems for WFI, PW and high-purity steam from Pharmatec
Customized quality units from Pharmatec
Pharmatec develops, constructs and manufactures: Ñ WFI storage and distribution
systemsÑ PW storage and distribution
systemsÑ Distribution systems for high-purity steam
P + I-Diagram
Pharmatec GmbHProcessing and Biotechnology systems
www.fa
berm
olde
nhau
er.de
0005/01
Pharmatec GmbHA Bosch Packaging Technology Company
Manfred-von-Ardenne-Ring 5 01099 Dresden GermanyTel. +49 351 2 82 78-0Fax +49 351 2 82 78-20www.pharmatec.de
Printed in Germany100 % chlorine free paper
� | Lorem ipsum dolor sit Processing and Biotechnology systems | 3
Upstream and downstream biotechnology units from Pharmatec
Processing and bio-technology systems from Pharmatec
Preparation systems, units for fermentation and purification In the field of biotechnology and processing units, Pharmatec develops, constructs and produces the following: Ñ Preparation units for hygienic,
aseptic and sterile processes, with isolation technology
Ñ Systems for inactivation and neutralization
Ñ Systems for sterile filtrationÑ Integration/complementing of
upstream and downstream processesÑ Fermentation systems
(in cooperation with partners) Ñ Sterilization units for substrate
solutionsÑ Provision of buffers for chromato-
graphy units with fraction collectorsÑ Systems to provide buffers and
prepare substratesÑ Harvest linesÑ Filtration systems (nanofiltration,
crossflow and ultrafiltration)
Isolating and purifying substances extracted by means of
bioprocessing is a multi-level process which sets high
demands in terms of unit technology and process control.
As a unit manufacturer, Pharmatec is a global service
provider acting as a partner to the pharmaceutical
industry. Fermentation media are complex mixtures of
different substances where the final product is intra-
cellular or in a diluted solution. At 40 % – 90 %, the recon-
ditioning costs make up a considerable amount of manuf-
acturing costs. The steps of separating out the solid
phase, cell disruption, concentration, purification and
formulation all come under the heading of downstream
processes. The solids can be separated using means such
as filtration, centrifugation and sedimentation. Cell dis-
ruption can be caused by mechanical methods, by osmo-
tic pressure or using enzymes. Pharmatec delivers units
for the preparation of buffer media and integrates units
for filtration and add-on chromatography units. For the
buffer preparation, the solid or liquid buffer substances
are placed in the containers and dissolved in purified
water or WFI (water for injection). Using ultrafiltration
modules integrated in the unit, the final product is con-
centrated before further reconditioning steps and after
chromatography steps. During filtration, other compo-
nents can be measured in depending on the conductivity
and permeate flow. A chromatography unit integrated into
the unit is available to further purify the product. The
buffer is supplied and the fractions collected using the
containers in the processing unit.
Example of a downstream processing unit (1 x 200 l, 4 x 600 l, 1 x 1,200 l)
Contact Pharmatec for the planning, development and
production of:Ñ Upstream and downstream biotechnology units Ñ Preparation systems Ñ CIP/SIP units Ñ Wastewater deactivation units
The growing amount of active substances which are
produced using biotechnology is changing the structure
of pharmaceutical production units. Highly complex
biochemical reaction mechanisms demand higher and
higher levels of purity and thus more efficient purifica-
tion steps in the units. Pharmatec’s processing and
biotechnology systems are characterized by many years
of experience in development and construction, as well
as of uncompromising production quality.
Overview of processing systemsÑ Preparation units for hygienic, aseptic and sterile
processes, with isolation technologyÑ Storage systems with transfer pipesÑ Systems for inactivation and neutralizationÑ Systems for sterile filtrationÑ Transfer and handling systems
Overview of biosystems Ñ Integration/complementing of upstream and
downstream processesÑ Fermentation systemsÑ Sterilization units for substrate solutionsÑ Provision of buffers for chromatography units
with fraction collectorsÑ Harvest linesÑ Filtration systems (nanofiltration, crossflow,
ultrafiltration)
� | Lorem ipsum dolor sit Processing and Biotechnology systems | 5
Bioprocess expertise from Pharmatec
Ñ Controlling the unit using PLC – at the client’s requestÑ Operation with an operating panel or PC
(various visualization systems possible) Ñ Complies with 21 CFR 11Ñ Can be connected to a higher-level process
controlling system Ñ Control in accordance with GAMP Ñ Construction avoids dead legs Ñ Pipes and fittings laid out to enable complete
evacuation Ñ Built entirely in 1.4404 or 1.4435 premium steel
Pharma Biotech procedures
Media Protection and Substrate Preparation
Sterilization
Fermentation
Product Packaging
Sterilization
upst
ream
dow
nst
ream
Residual disposal
ExpertisePharmatec
Product
Ñ Surface roughness < 0.8 µm Ñ Welding mainly carried out using orbital welding
technique Ñ Unit documentation in accordance with FDAÑ Optional: design in 1.4539 premium steel Ñ Optional: Smoother surface thanks to special
treatment such as electropolishing Ñ Optional: Additional tests such as video endoscopy,
X-ray test Ñ Optional: Compliance with delta-ferrite content
pursuant to BN2
Example of a bioprocessing unit (2 x 1,000 l)
Harvesting
Product Purification
Integration of filtration systems (UF/NF)
Integration of separators
Integration of chromatographs
Integration of buffer/ processing vessels
CIP
CIP
ExpertiseBoschbusiness union
Upstream and downstream biotechnology units from Pharmatec
� | Lorem ipsum dolor sit Processing and Biotechnology systems | 7
Preparation systems from Pharmatec
Preparation system expertise from Pharmatec
Some of the main components of a preparation system are: Ñ Pressure-resistant processing
containers in accordance with guidelines on pressurized devices, with or without double wall
Ñ Magnetic mixers with frequency regulator
Ñ Sterile ventilation and product filters with certified integrity
Ñ Pumps: circulation, metering, vacuum or transfer pumps
Ñ ValvesÑ Calibrated metersÑ Automation system and process
controlÑ Integration of preparation isolators
Example of a preparation system (preparation vessels 3 x 500 l, 1 x 50 l; buffer vessel 1 x 125 l; CIP vessel 150 l)
Preparation systems with RAPS
(Restricted Access Barrier Systems)
Pharmaceutical processing units are becoming more and
more complex, and set extremely high demands for
operator safety, protection against contamination and
product protection, not only in the field of bioproces-
sing. Despite the degree of automation in the field of
preparation, manual interventions are absolutely neces-
sary to implement formulations. Processing units to
produce cytostatics or other products which inhibit
cellular growth often require manipulation when adding
active substances and solid or liquid substances in
extremely small pre-weighed quantities. In this case,
precise doses can only be added manually. The ideal
solution for a method which is very safe, protects the
operating staff and protects the product from contami-
nation is “Restricted Access Barrier Systems”, or RAPS
for short, or isolators. Both companies have a long
tradition of the combination and connection of Pharma-
tec processing units with Bosch isolator systems, proce-
dural calculation, and expertise in cleaning and sterili-
zing complex isolator/unit systems.
Example of a preparation isolator
Pharmaceuticals are substances or preparations which are
designed for use on or in the bodies of humans or animals.
The fundamental rules for their quality and the substances
and processes used in manufacturing them are clearly
defined and described in international laws. These sets of
rules are used as a principle in planning and project plan-
ning for sterile preparation systems. The high standards
set down for cleanliness and sterility when manufacturing
pharmaceuticals reveal the obvious value placed upon
processing units of this type in the pharmaceutical
industry. Pharmatec has made this high status the focus of
its core business and can provide complete production
units for manufacturing parenteral or oral products all over
the world. Due to the variety of different processing steps
and technological procedures, concepts for preparation
lines vary; Pharmatec engineers adjust them to fit custo-
mers’ requirements perfectly. Procedural processes for
the manufacturing of the above products often start
with the introduction of raw and auxiliary materials, with
liquids or solids being measured out extremely precisely
using weighing systems or flow rate metering. Mixing
processes with high-performance mixers which are
gentle on the product; temperature control procedures
with extremely close tolerances and very high precision,
and sterilization programs, secure the long-term future
of the company’s processing expertise in pharmaceuti-
cal unit construction. To maintain values such as the pH
value, conductivity, concentration and density, which are
critical to the process, process engineers and auto-
mation engineers create special program flows which
are turned into GAMP-compliant automation systems to
fulfill the customer’s wishes.
Processing and Biotechnology systems | 9
CIP/SIP units from Pharmatec
Mobile CIP systems from Pharmatec
CIP/SIP biotechnology units from Pharmatec are individually adjusted to customers’ requirements. Pharmatec develops, constructs and manufactures CIP/SIP units for: Ñ cleaning buffer preparation
systems, fermenters, filling machines
Ñ single vessel (mobile or fixed)Ñ or complex multi-vessel unitsÑ closed-loop or single-use cleaning
systemsÑ complete integration into the
processing units to be cleaned
Pharmatec’s services: Advice and
planning, all the way down to putting
together one or more CIP unit sys-
tems, including the supply and return
lines to the processing units and
piping to be cleaned. To automate
the process, validated software
modules are used to create a greater
degree of standardization. The start-
up and qualifying costs are reduced
thanks to effective project planning.
At the same time, the high reliability
of the tried and tested fast-track
module increase the units’ availabi-
lity, allow them to be inspected
safely, make troubleshooting easier
and thus contribute to the safety and
reproducibility of the procedures.
Pharmatec’s mobile cleaning centre is designed as a
CIP unit and automatically carries out procedural steps
in the cleaning of important components which come
into contact with products in processing units and
filling and packaging machines. The unit is designed as
a mobile unit which is ready for immediate operation.
Components: Ñ Tank, 500l, for cleaning solution/rinsing waterÑ CIP supply pump with built-in frequency converterÑ CIP return pump with built-in frequency converter Ñ Measuring pumps for adding alkaline and
acidic cleaning agentsÑ Electric/steam heated exchangerÑ Chassis (approx. 2,500 x 1,200 x 2,000 mm
[L x W x H]) Ñ Pipes, valvesÑ Pressure reduction and sterile filter for
compressed airÑ Metering and regulating devices Ñ Control cabinet with power section and unit control Ñ Electrical and pneumatic installationÑ Control system with operating systemÑ External interface
Conceptual diagram of CIP unit Ñ Compact, modular unit structureÑ Tried and tested standard compo-
nents used from selected suppliers Ñ Design with little or no dead space
makes it easy to clean yourself Ñ Optional: SIP design (for inline
sterilization)
Example of a four-vessel CIP unit (4,000 l RW-model; 3 x 2,000 l pre-rinsing water, acid, leach)
CIP – Cleaning in PlaceSIP – Sterilization in PlaceDIP – Drying in Place
CIP return
Shell-and-tube heat exchanger
CIP supply
Metering pump
Detergents
CIP tank
Item to be cleaned
Mobile CIP unit
Processing and Biotechnology systems | 11
Wastewater inactivation units from Pharmatec
Inactivation units from Pharmatec
Biotech procedures to produce active substances are
widespread in the pharmaceutical industry. One important
link in the production chain is disposing of production
waste. The law sets down regulations on this point to
minimize risks to people and to the environment. For
inactivation, a wide temperature range is available, from
80 – 135°C, which can be selected depending on the type
and concentration of the bacteria to be inactivated.
Thanks to the construction of the unit and the controls,
which are adjusted to it, the wastewater is kept in the unit
in liquid form above boiling (at normal pressure).
Pharmatec develops, constructs and produces inactivation units which can run continuously.Ñ Thermal inactivation of wastewater
contaminated with biological materials Ñ Treated wastewater fulfils all legal
requirements (safety level BSL 1, BSL 2, BSL 3)
Ñ Lower energy use than with units which do not run continuously
Example of an inactivation unit which runs continuously (2,500 –4,000 l/h)
Thanks to the adjustable volume flow at which the
wastewater is conducted through the unit, the inactiva-
tion level can be adjusted to the quantity of wastewater
occurring at any time. This minimizes energy-sapping
starting-up and switching-off procedures. The heat
maintenance section is designed as a coil and also acts
as the base of the unit. Above it come three heat
exchangers (heater, recuperator, cooler). To detect any
leaks, the base stands in a basin equipped with liquid
sensors.
Biosafety level (BSL) classification
When dealing with biological agents such as viruses,
bacteria and fungi, corresponding safety regulations
must be complied with in accordance with the law on
genetic engineering. Depending on the biosafety level,
the danger of infection due to contact with the biologi-
cal agents must be avoided by using appropriate sealant
systems (e. g. double mechanical seals with isolating
pressure vessels), (de-)aeration, sampling systems and
sterile barriers.
BSL 1Ñ Risk level: Very little or no risk to individuals or the
population. Ñ Potential risk: Humans or animals are not expected
to fall ill.
BSL 2Ñ Risk level: Moderate risk to individuals, low risk to
the population. Ñ Potential risk: Humans or animals may fall ill, but
there is no serious danger to lab personnel, the
population, livestock or the environment. Contacts in
the lab can lead to successful infection but effective
treatment and prevention measures exist. There is
limited risk of spreading.
BSL 3Ñ Risk level: High risk to individuals, low risk to the
population.Ñ Potential risk: Humans or animals are expected to
become seriously ill, but it is not usual for the infec-
tion to spread from one infected host to the next.
There are effective treatment and prevention
measures.
BSL 4Ñ Risk level: High risk to individuals and the
population. Ñ Potential risk: Humans or animals are expected to
become seriously ill, but it is not usual for the infec-
tion to spread from one infected host to the next.
There are effective treatment and prevention
measures.